Key facts
- It has raised $34.4M; the latest was Later Stage VC ($46.5M) in Nov 2025.
- Notable investors include INNVIERTE SICC, Inveready Asset Management, Clave (Pamplona), CDTI Innvierte, Alentia Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Amadix
- ·The full record, as it builds
Funding rounds
No funding rounds for Amadix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amadix
Developer of cancer detection technologies designed to detect tumors years in advance, before the symptoms appear. The company's technologies are oriented towards non-invasive early cancer detection and avoiding the complications of existing invasive procedures, such as tumor biopsies, enabling doctors to provide suitable treatment to the patient.
- Sector
- Healthcare
- HQ
- Valladolid, Spain
- Founded
- 2010
- Employees
- 41
- Website
- amadix.com/
- Ownership
- Privately Held (backing)
Amadix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amadix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amadix in its N-PORT filings yet. We sweep new filings monthly.